ARGO protocol 1

ARGO clinical trial protocol

The ARGO clinical trial protocol has been published in the “New Treatments for Keratoconus” Special Issue of International Ophthalmology.

The publication is open access and available at

The manuscript includes exhaustive information on the ARGO clinical trial design and research protocol, which is targeting to validate #theranostics for personalized and precision corneal cross-linking for treating keratoconus.

Regensight is a startup Company committed in the dissemination of the clinical trial design for the benefit of the entire medical community and the patients they serve. This is a part of the ethical mandate, mission and vision statement of our Company.

Comments are closed.